Ubs Group Ag Earnings Calls
| Release date | Jul 29, 2026 |
| EPS estimate | £0.85 |
| EPS actual | £0.87 |
| EPS Surprise | 2.35% |
| Revenue estimate | 13.23B |
| Revenue actual | 13.35B |
| Revenue Surprise | 0.91% |
| Release date | Apr 29, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | 10.373B |
| Revenue actual | - |
| Release date | Feb 04, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | 9.274B |
| Revenue actual | - |
| Release date | Feb 20, 2024 |
| EPS estimate | - |
| EPS actual | -£0.368 |
| Revenue estimate | - |
| Revenue actual | 9.068B |
Last 4 Quarters for Ubs Group Ag
Below you can see how 0R3T.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 20, 2024 |
| Price on release | £24.40 |
| EPS estimate | - |
| EPS actual | -£0.368 |
| Date | Price |
|---|---|
| Feb 14, 2024 | £24.25 |
| Feb 15, 2024 | £24.42 |
| Feb 16, 2024 | £24.48 |
| Feb 19, 2024 | £24.50 |
| Feb 20, 2024 | £24.40 |
| Feb 21, 2024 | £24.50 |
| Feb 22, 2024 | £24.63 |
| Feb 23, 2024 | £24.72 |
| Feb 26, 2024 | £24.99 |
| 4 days before | 0.619% |
| 4 days after | 2.42% |
| On release day | 0% |
| Change in period | 3.05% |
| Release date | Feb 04, 2026 |
| Price on release | £35.78 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jan 29, 2026 | £36.97 |
| Jan 30, 2026 | £36.72 |
| Feb 02, 2026 | £36.99 |
| Feb 03, 2026 | £37.46 |
| Feb 04, 2026 | £35.78 |
| Feb 05, 2026 | £33.91 |
| Feb 06, 2026 | £33.48 |
| Feb 09, 2026 | £34.12 |
| Feb 10, 2026 | £33.99 |
| 4 days before | -3.22% |
| 4 days after | -5.00% |
| On release day | -5.23% |
| Change in period | -8.06% |
| Release date | Apr 29, 2026 |
| Price on release | £34.91 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 23, 2026 | £33.04 |
| Apr 24, 2026 | £32.33 |
| Apr 27, 2026 | £32.46 |
| Apr 28, 2026 | £33.12 |
| Apr 29, 2026 | £34.91 |
| Apr 30, 2026 | £33.73 |
| May 01, 2026 | £33.73 |
| May 05, 2026 | £34.04 |
| May 06, 2026 | £35.84 |
| 4 days before | 5.64% |
| 4 days after | 2.68% |
| On release day | -3.38% |
| Change in period | 8.47% |
| Release date | Jul 29, 2026 |
| Price on release | £43.31 |
| EPS estimate | £0.85 |
| EPS actual | £0.87 |
| EPS surprise | 2.35% |
| Date | Price |
|---|---|
| Jul 23, 2026 | £42.74 |
| Jul 24, 2026 | £42.02 |
| Jul 27, 2026 | £42.95 |
| Jul 28, 2026 | £42.91 |
| Jul 29, 2026 | £43.31 |
| Jul 30, 2026 | £42.06 |
| Jul 31, 2026 | £43.11 |
| Aug 03, 2026 | £42.91 |
| Aug 04, 2026 | £43.07 |
| 4 days before | 1.33% |
| 4 days after | -0.543% |
| On release day | -2.87% |
| Change in period | 0.784% |
Ubs Group Ag Earnings Call Transcript Summary of Q2 2026
UBS reported a strong Q2 2026 with broad-based revenue and profit growth across its core franchises. Group revenues rose 16% to $13.3bn, underlying pretax profit was $3.9bn (up 45% YoY) and return on CET1 capital was ~16–17%. Invested assets hit a record $7.3tn, driven by robust inflows into Global Wealth Management (GWM) and Asset Management, while the Investment Bank delivered a record quarter, particularly in equities and capital markets, without materially expanding the balance sheet. Cost and integration progress remains a key theme: cumulative gross cost savings of $12.6bn since end-2022 (on track for $13.5bn by year-end), headcount down ~28% vs 2022, and >90% of legacy applications decommissioned as the Credit Suisse integration nears completion. Capital and shareholder returns: CET1 ratio was 14.4% at quarter end, and the board launched a new $3bn buyback program to be completed by no later than Q2 2027 (with at least $1bn targeted in the next three months), noting timing is subject to performance, maintaining ~14% CET1 and Swiss Parliament deliberations on foreign-subsidiary capitalization. Division highlights: GWM pretax profit +38% with strong mandate penetration and lending momentum; Personal & Corporate Banking (Switzerland) returned to growth with loan renewals and expanding client activity; Asset Management AUM >$2.2tn but revenues impacted by the prior O’Connor sale; Non-core & Legacy continuing to shrink with operating expenses (ex-litigation) expected to exit 2026 around $400m. Management reiterated confidence in meeting or exceeding 2026 exit-rate ROE and cost/income targets, while cautioning on macro/geopolitical uncertainty, potential volatility in rates and inflation, and ongoing adviser turnover pressure in U.S. wealth (expected to normalize through 2026).
Sign In
Buy 0R3T